Get the latest on conferences, webinars, publications, the AACC Annual Scientific Meeting & Clinical Lab Expo, as well as governance, awards, and other association news.
AACC Remembers Past President Dr. Norbert W. Tietz
Norbert W. Tietz, PhD, an AACC member since 1955 and author of the seminal textbook “Fundamentals of Clinical Chemistry,” passed away on May 23, 2018 at the age of 91.
AACC Announces 2019 Candidates
Thomas M. Annesley, PhD, DABCC, FAACC, Chair of the 2018 Nominating Committee, has announced the slate of candidates selected by the Nominating Committee for the 2019 AACC elections.
AACC Remembers Past President Dr. Kurt M. Dubowski
Kurt M. Dubowski, PhD, LLD, DABCC, DABFT, a pioneer in alcohol and substance abuse testing, passed away on October 23, 2017 at the age of 95.
FDA Defers Decision on LDT Guidance
Last Friday’s announcement by the Food and Drug Administration (FDA) that it would not finalize guidance regulating laboratory developed tests (LDTs) provides a reprieve to the laboratory community.
In Memoriam: Dr. Richard Donald Krause
Richard Donald Krause, PhD, DABCC, a long-time AACC member and committed researcher and clinical laboratorian in his native Alberta, Canada, died on October 25, 2016.
AACC Elects Dennis J. Dietzen, PhD, DABCC, FACB, as 2018 President
AACC is pleased to announce that Dennis J. Dietzen, PhD, DABCC, FACB, has been elected to serve on the AACC Board as president-elect beginning in January 2017, followed by successive terms as the association’s 69th president in 2018 and past president in 2019.
Lab Tests Online Honored With 2016 Digital Health Award
AACC’s public resource on lab testing received merit award among consumer website.
CLN, CLN Stat Recognized With Healthcare Industry Publication Awards
AACC news publications honored in three editorial, graphics categories.
CLN, CLN Stat and AACC Artery Honored With Prestigious International Awards
AACC publications and online member community recognized in eight Hermes Creative Award categories.
CDC Warns Travelers, Especially Pregnant Women, About Zika Virus
The U.S. Centers for Disease Control and Prevention has issued a travel alert for more than 20 countries, primarily in South and Central America and the Caribbean, because of an outbreak of Zika virus, an infectious disease spread by mosquitos.
New Year's Greetings from AACC President Patricia Jones
Dr. Jones shares her vision for AACC and the field of laboratory medicine in 2016.
Take a Survey About How Your Lab Adds Value to Patient Care
The Coordinating Council for the Clinical Laboratory Workforce asks that the leadership team of your lab complete a survey to help identify measures of value that laboratory professionals add to the healthcare system.
Message from 2015 AACC President David D. Koch
2015 has been a year of many accomplishments, including the approval of a new governance framework for AACC.
AACC Elects Michael J. Bennett, PhD, as 2017 President
AACC is pleased to announce that Michael J. Bennett, PhD, has been elected to serve on the AACC Board as president-elect beginning in January 2016, followed by successive terms as the association’s 68th president in 2017 and past president in 2018.
AACC Remembers Past President George N. Bowers Jr., MD
George N. Bowers Jr., MD, passed away at the age of 89 on August 16. Dr. Bowers served as AACC president in 1974, and was considered one of the leaders of his generation in the field of laboratory medicine.
AACC Elections Process Starts September 1
AACC’s month-long election process for its Board of Directors will begin on September 1 and run through September 30. The slate of candidates, announced in June by AACC Secretary David G. Grenache, PhD, includes Michael J. Bennett, PhD, and Elizabeth L. Frank, PhD, as candidates for president-elect.
Announcement of Office Relocation
AACC is pleased to announce that the organization has moved to a new office location. As of August 7, AACC’s address is 900 Seventh Street, NW, Suite 400, Washington, DC, 20001.
Call for Applications: Editor-in-Chief of The Journal of Applied Laboratory Medicine
AACC is seeking applications for Editor-in-Chief of its new journal, The Journal of Applied Laboratory Medicine: An AACC Publication. The deadline for applications is July 20, 2015. The new journal, which will begin publishing in spring 2016, will be a forum for peer-reviewed, applied research on clinically relevant laboratory topics and commentary on the practice of laboratory medicine.
AACC President Dave Koch's Letter on Governance
As the premier organization for research, education, and advocacy for practitioners of laboratory medicine, AACC has changed and grown since its founding in 1948 along with the field. The current governance structure developed organically, growing with the organization to fit the needs at the time. With a renewed emphasis on strategy and forward thinking, we have undertaken a review of the governance with an eye to devise a system that works for the modern AACC and the needs of today’s laboratory professionals. We want to be sure that our structure aligns with the Strategic Plan of AACC and supports its ambitious goals.
Renowned Toxicologist Professor Hans H Maurer Will Keynote AACC's Mass Spectrometry Conference
Dr. Hans H. Maurer, a distinguished toxicologist and co-developer of two essential mass spectral spectral libraries, will be the keynote speaker at AACC’s 5th Annual Mass Spectrometry and Separation Sciences for Laboratory Medicine Conference, October 1-2, 2015 in Chicago, Illinois.
AACC Announces New Dates for the 2016 AACC Annual Meeting & Clinical Lab Expo
AACC announces a date change for the 2016 AACC Annual Meeting & Clinical Lab Expo in Philadelphia, due to the scheduling of the Democratic National Convention in Philadelphia during the same week originally scheduled for AACC’s meeting. The new dates for AACC’s 2016 meeting are July 31–August 4, 2016, just one week later than the original planned dates.
Dr. Loretta Doan Named Vice President of Policy and Global Affairs at AACC
AACC is pleased to announce that Loretta L. Doan, PhD, has assumed the position of vice president of policy and global affairs effective today. Prior to joining AACC, Doan served as director of science policy at the Endocrine Society, an organization representing more than 18,000 scientists and clinicians. At the Endocrine Society, she led a diverse portfolio of science policy initiatives that advanced the field of endocrinology, including a program focused on the standardization of hormone assays.
AACC Local Sections Compete in First Ever Local Section Membership Challenge
At the start of this year, AACC launched its first ever Local Section Membership Recruitment Challenge, which asked each Local Section to recruit 25 new members by October 31, 2014. Now that the challenge has come to a close, AACC is pleased to announce that through it, our Local Sections recruited 96 new members in total.
Patricia M. Jones Chosen as AACC President-Elect
The AACC membership has elected three new members to the AACC Board of Directors and two new members to the Nominating Committee who will take office in 2015.
An In-Depth Look at Thyroid Testing
An hour-long AACC webinar on November 20 will feature National Institutes of Health senior scientist and researcher Steven J. Soldin, MD, discussing how liquid chromatography-tandem mass spectrometry (LC-MS/MS) is challenging laboratories to think about thyroid testing in new ways. Soldin’s session will address contemporary issues encountered with thyroid testing, as well as case studies to demonstrate how certain issues can affect patients.
How Human Resource Management, Quality and Risk Management Strategies Affect Patient Safety
Two faculty members of AACC’s Patient Safety Essentials for Laboratory Professionals online certificate program recently spoke with CLN Stat about how risk management and quality improvement strategies and effective personnel management can go a long way toward improving patient safety.
A Primer on Designer Drugs
A new guide available through AACC Press offers laboratorians a quick reference tool for identifying so-called “designer drugs.” The moniker applies to the compounds created by “modifying structures of abused drugs to circumvent legal restrictions and evade detection,” according to a synopsis of the Quick Guide to Designer Drugs.